	US 12,258,406 B2
	Antibodies that bind CD3 Epsilon
Aaron Sato, Burlingame, CA (US); Qiang Liu, Palo Alto, CA (US); Mary Mathieu, South San Francisco, CA (US); and Linya Wang, Milpitas, CA (US)
Assigned to Twist Bioscience Corporation, South San Francisco, CA (US)
Filed by Twist Bioscience Corporation, South San Francisco, CA (US)
Filed on Mar. 23, 2022, as Appl. No. 17/702,660.
Claims priority of provisional application 63/165,656, filed on Mar. 24, 2021.
Prior Publication US 2022/0348659 A1, Nov. 3, 2022
Int. Cl. C07K 16/28 (2006.01); C07K 16/18 (2006.01); C12N 15/10 (2006.01)

CPC C07K 16/2809 (2013.01) [C07K 16/18 (2013.01); C12N 15/1068 (2013.01); C07K 2317/31 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01)]

8 Claims

1. An antibody or antibody fragment thereof that binds CD3 epsilon, comprising an amino acid sequence as set forth in any one of SEQ ID NOs: 25-32.